GLP-1 / GIP Agonists

Peptides: independent lab report for each listed batch · Water: documentation varies by vial (see product page)

Research-grade GLP-1 and GIP receptor agonist peptides for metabolic and endocrinology research. Includes tirzepatide (dual GIP/GLP-1), semaglutide (GLP-1), and retatrutide (triple GIP/GLP-1/glucagon). Each listed batch has an independent HPLC purity report; measured purity is stated on that batch’s report. For in-vitro research use only.

Showing all 4 results

    Retatrutide research vial

    Retatrutide

    10 mg · 30 mg vials · lyophilized

    Retatrutide is a synthetic triple-receptor agonist targeting the GIP, GLP-1, and glucagon receptors simultaneously. It is used as…

    MW 4731.3 g/mol
    Tirzepatide research vial

    Tirzepatide

    10 mg · 30 mg vials · lyophilized

    Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist used as a reference compound in in-vitro research studying simultaneous…

    MW 4813.5 Da
    Semaglutide research vial Sale!

    Semaglutide

    10 mg vial · lyophilized

    Research-grade Semaglutide — GLP-1 receptor agonist analogue, lyophilized, high purity. Independently third-party tested. Each RR vial has a…

    MW 4113.6 Da Batch SEM010-001
    Cagrilintide research vial

    Cagrilintide

    5 mg vial · lyophilized

    Research-grade Cagrilintide — long-acting amylin receptor agonist analogue, lyophilized, high purity. Independently third-party tested. Each RR vial has…

    MW 4409.0 g/mol Batch CAG005-001
✓ Added to cart View Cart →